The 20 Best Dysembryoplastic Neuroepithelial Tumors (DNET) Doctors Near Me in Ann Arbor, MI

Dr. Wajd Al-Holou was raised in southeast Michigan. After attending the University of Michigan Medical School, where he graduated with the highest award for research, he then began a 7-year Neurosurgery residency at the University of Michigan. Upon completion of residency in 2016, he completed a Complex Neurosurgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX. His training focused on the management of complex brain tumors, spinal tumors, and skull base malignancies.Dr. Al-Holou specializes in the management of complex brain tumors, primarily focusing on gliomas and metastases to the brain. Dr. Al-Holou has expertise in the use of awake mapping techniques, microsurgery, and image-guidance to maximize tumor removal in the safest possible manner. He also specializes in the management of meningiomas and spinal tumors.Dr. Al-Holou is the co-founder and co-director of the Michigan Medicine Multidisciplinary Brain Tumor Clinic (M3BTC). As a member of this Neuro-Oncology multidisciplinary team, he works strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient.Currently, he is a member of the AANS/CNS Executive Committee of the Section on Tumors. He served as the Co-Chair for Tumor Section Scientific Program for the American Association of Neurological Surgeons (AANS) in 2018 and is a member of the Society of Neuro-Oncology. He also serves as an editor for cancer journal, BMC Cancer.Dr. Al-Holou is committed to research and education in Neurosurgery and his life-long goal is improving the survival and outcomes for patients with tumors. His research interest focuses primarily on understanding the genetic mechanisms of recurrence in glioblastoma, and in identifying precision medicine therapies to target resistant tumors. Dr. Al is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Astrocytoma, Oligodendroglioma, and Awake Craniotomy. Dr. Al is board certified in Neurological Surgery.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Mihaylova is board certified in Neurology, Clinical Neurophysiology, and Epilepsy.

Neena Marupudi is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Marupudi is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 53 other conditions, according to our data. Her clinical expertise encompasses Hydrocephalus, Tethered Cord Syndrome, Chiari Malformation Type 1, Rhizotomy, and Laminectomy. Dr. Marupudi is board certified in Neurological Surgery.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

Dr. Magge is a Clinical Professor of Neurosurgery and serves as the Surgical Director of the Pediatric Brain Tumor Program. His clinical practice encompasses all types of pediatric neurosurgery, with particular clinical and research interests in pediatric brain tumors, craniosynostosis (endoscopic and open surgery), and pediatric neurovascular disease (including AVM’s and moyamoya disease). His brain tumor research has focused on finding better treatments for diffuse intrinsic pontine gliomas (DIPG’s) and methods for liquid biopsy. He has been involved in multicenter clinical trials. In the field of craniosynostosis, he has been the principal investigator of a multicenter trial examining long term outcomes of children with craniosynostosis treated with either endoscopic or open surgery. He also started the first endoscopic craniosynostosis surgery program in the Washington, DC area and helped to grow a busy craniosynostosis practice in California. He has authored numerous scholarly papers, and he is a regular speaker at national and international conferences. Dr. Magge works to find the best treatment for each patient in the least invasive method possible.Prior to joining University of Michigan Health, Dr. Magge served as the Director of Neurosurgery and Co-Director of the Children’s Hospital of Orange County Neuroscience Institute and Professor of Clinical Neurosurgery at University of California Irvine. Prior to that, he was a faculty member in the Division of Pediatric Neurosurgery at Children’s National Hospital in Washington, DC, where he started the pediatric neurosurgery fellowship program and served as fellowship director.Dr. Magge grew up in Cincinnati, Ohio, and he attended Harvard College for his undergraduate studies, where he majored in biochemistry. He then obtained his medical degree from Harvard Medical School, graduating in 2001. During medical school, he completed a 1 year Howard Hughes research fellowship at the NIH. He then completed neurosurgery residency training at the University of Pennsylvania in 2008, and fellowship training in pediatric neurosurgery at Boston Children’s Hospital in 2009. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Plagiocephaly, Cortical Dysplasia, Craniectomy, and Posterior Fossa Decompression. Dr. Magge is board certified in Neurological Surgery and Pediatric Neurosurgery.

Simon Glynn is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Glynn is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Epilepsy. Dr. Glynn is board certified in Neurology and Epilepsy.

Dr. B. Gregory Thompson was born in Kansas City, Missouri, the oldest son in a family of eleven children. Dr. Thompson attended Harvard College, where he played football and studied English and biology. He graduated from the University of Kansas School of Medicine and subsequently entered neurosurgery residency training at the University of Pittsburgh, where he did elective rotations in neurology at Queen Square in London, England, and as a Medical Staff Research Fellow at the National Institutes of Health in Bethesda, Maryland.Following his residency in Pittsburgh, Dr. Thompson did a neurovascular and skull base surgery fellowship at the Barrow Neurological Institute and began his academic career at the University of Utah. He was then recruited to the University of Michigan.After 10 years in practice, Dr. Thompson recognized that the rapid technological and clinical development of interventional neuroradiology was a force rapidly changing cerebrovascular surgery and training, and so he returned to training as a fellow in Endovascular Neurological Surgery (ENS) at Thomas Jefferson University in Philadelphia.Upon returning full time to the University of Michigan in 2005, he became Vice Chairman of the Neurosurgery Department and established a curriculum for neurosurgery resident education in ENS. He also subsequently established a “dual training” cerebrovascular fellowship which encompasses both endovascular and advanced microsurgical techniques.Working also with a cranial base team of six otologists at Michigan, Dr Thompson has operated more than 1,000 patients with vestibular schwannomas, and their Michigan team has reported significantly improved hearing preservation results with the Middle Fossa Approach.Dr. Thompson received the University of Michigan’s Medical Student Award for Teaching Excellence in Neuroscience, the University’s Outstanding Clinician Award, and was an inaugural member of the University’s League of Clinical Excellence. He was honored with the Cerebrovascular Section’s Alfred J. Luessenhop Award in Cerebrovascular Surgery in 2011, and was appointed as a Director of the American Board of Neurological Surgery in 2012. He currently serves as the Chair of the ABNS. Dr. Thompson and his wife Ramona have 7 children and reside in Ann Arbor.50813181. Dr. Thompson is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, Thrombectomy, and Gastrostomy.

Dr. Jason Heth attended The University of Iowa where he received his medical degree and also completed his residency in Neurosurgery. Dr. Heth then completed additional training in Skull Base Neurosurgery, completing a fellowship at the University of Arkansas for Medical Sciences. After completing his fellowship, he joined the faculty of the University of Michigan. Dr. Heth specializes in brain tumor treatment, including surgical removal, radiosurgery, and basic research. His primary areas of interest focus on gliomas, glioblastoma, brain metastasis, and meningiomas. He is also involved in medical student education and quality improvement programs at the University of Michigan. Dr. Heth is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy. Dr. Heth is board certified in Neurological Surgery.

Dr. Venkatakrishna Rajajee completed his medical training at the Madras Medical College in India. He completed his residency in Neurology at the Mount Sinai Medical Center, New York in 2003, followed by fellowships in Stroke/ Vascular Neurology and Neurological Critical Care at the UCLA Medical Center 2003-2005. In addition, he has several years of experience in private practice as an attending physician in medical/ surgical intensive care units. He joined the University of Michigan’s neurosurgery department 2008 as faculty neurointensivist and vascular neurologist. He has served as the medical director of neurocritical care since 2014 and as co-director of the comprehensive stroke center since 2017.Dr. Rajajee has had a clinical, educational, and research interest in critical care ultrasound since 2007. He is a diplomate of the National Board of Echocardiography. He has published several articles on optic nerve ultrasound and transcranial doppler in neurocritical care, and helped pioneer the use of real-time ultrasound guidance during bedside tracheostomy in 2011. Dr. Rajajee developed and directed the Neurocritical Care Society’s (NCS) annual critical care ultrasound workshop between 2012-2014, and has served on the Society of Critical Care Medicine’s (SCCM) Ultrasound Committee. He currently coordinates the University of Michigan’s multidisciplinary critical care ultrasound lecture series.His other interests include the monitoring and management of patients with severe Traumatic Brain Injury (TBI). In 2013, Michigan Medicine signed a memorandum of understanding on collaboration in research and education with the All India Institute of Medical Sciences (AIIMS), New Delhi, with TBI as a major focus. As part of this collaboration, Dr. Rajajee has received funding from the National Institutes of Health (NIH) to study techniques of intracranial pressure assessment applicable to low and middle income nations. He has also received funding from the Department of Defense (DoD) to evaluate noninvasive techniques to assess the brain following TBI.He is a former chair of the Neurocritical Care Society’s Guidelines Committee, and the GRADE methodologist of the NCS guidelines for neuroprognostication in neurocritical care. He is the first author of the 2023 Guidelines for Neuroprognostication in Comatose Adult Survivors of Cardiac Arrest. Dr. Rajajee is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, Gastrostomy, and Transmyocardial Revascularization.

Nathan Clarke is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Clarke is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Clarke is board certified in Neurology.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

After completing his chief residency at the University of Virginia, Dr. Sagher accepted a position on the neurosurgical faculty at the University of Michigan. He became Chief of Neurosurgery at the Ann Arbor Veterans Administration Hospital, a position he held until 1996. He then completed a fellowship in Pain and Functional Neurosurgery at the Oregon Health Sciences University, and took over as the Director of Neuromodulation at the University of Michigan. As the primary functional neurosurgeon at the University of Michigan, Dr. Sagher takes care of such problems as epilepsy, pain, Parkinson's Disease and other movement disorders. Dr. Sagher is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). He has served on the Executive Council on the AANS/CNS Joint Section on Pain, which he chaired from 2003 to 2005. Special Interests: The treatment of epilepsy, pain, movement disorders, and brain tumors in functionally important regions. Dr. Sagher is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Meningioma, Seizures, Awake Craniotomy, and Microvascular Decompression. Dr. Sagher is board certified in Neurological Surgery.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Nasser Yaghi is Clinical Assistant Professor of Neurosurgery and Director of Neurosurgical Oncology at University of Michigan Health-Sparrow in Lansing. He earned his Bachelor of Science degree from Texas A&M University and Doctor of Medicine degree from Baylor College of Medicine. He completed Neurosurgery residency at Oregon Health and Science University and went on to complete fellowship in Neurosurgical Oncology under the mentorship of Dr. Nader Sanai at the Barrow Neurological Institute. Dr. Yaghi’s clinical interests include resection of benign and malignant brain tumor, with special interest in eloquent cortex brain tumors requiring intraoperative language and motor mapping. He has a strong research interest in glioma immunotherapy and has previously worked in the laboratories of Dr. Amy Heimberger at MD Anderson Cancer Center with an HHMI grant and Dr. Mark Gilbert at the National Institutes of Health. He has most recently developed skills in early phase clinical trials for drug development at the Ivy Brain Tumor Center. When not at work Dr. Yaghi loves to spend his time exploring hiking trails, trail running, long distance biking, mountain biking, fly fishing, and snowboarding. His family owns and operates a pizzeria business in Texas called Yaghi’s Pizzeria in which all family members have worked, and recently his family has entered the cattle business with a cattle ranch in Western Colorado. Dr. Yaghi is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Hydrocephalus.

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Giulia Benedetti is a Neurologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Benedetti is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Absence Seizure, and Lissencephaly 1. Dr. Benedetti is board certified in Neurology W/Spec Qual Child Neuro and Epilepsy.

Nicole Pariseau is a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Pariseau is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 122 other conditions, according to our data. Her clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Conversion Disorder, and Memory Loss. Dr. Pariseau is board certified in Neurology W/Spec Qual Child Neuro.